Here’s what you should know.
1. The test uses nanotechnology and laser-based blood analysis to create a fingerprint specific to blood cancer. Researchers analyze patient samples against the fingerprint to determine if they have bowel cancer.
2. The initial study involved 160 patients from the Swansea area in Wales. Cancer Research Wales funded the study.
3. A clinical trial is set to begin in 2017.
4. If the clinical trial is successful, the test would be used in National Health Service hospitals.
5. NHS awarded the study a Research Excellence award.
More articles on gastroenterology/endoscopy:
GI leader to know: Dr. Ivan Friedrich of The Gastroenterology Group of Northern New Jersey
AGA creates program to connect international GI physicians with US: 3 things to know
Olympus’ Endocuff receives FDA 510(k) clearance of claims: 4 notes
